Phibro Animal Health Corporation revised earnings guidance for the fiscal year ending June 30, 2023. For the year, the company expects net sales of $960 million - $1 billion (unchanged); net income of $34 million- $38 million, from $39 million- $43 million; diluted EPS of $0.84 - $0.94, from $0.96 - $1.06.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.23 USD | -0.92% | +0.66% | +57.43% |
05-09 | Transcript : Phibro Animal Health Corporation, Q3 2024 Earnings Call, May 09, 2024 | |
05-08 | Earnings Flash (PAHC) PHIBRO ANIMAL HEALTH CORPORATION Posts Q3 EPS $0.31, vs. Street Est of $0.29 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.43% | 738M | |
-11.64% | 79.57B | |
+14.09% | 8.4B | |
-2.64% | 3.18B | |
+15.71% | 1.67B | |
-1.11% | 1.64B | |
-17.54% | 1.38B | |
+0.59% | 1.32B | |
-4.96% | 1.24B | |
+4.11% | 1.12B |
- Stock Market
- Equities
- PAHC Stock
- News Phibro Animal Health Corporation
- Phibro Animal Health Corporation Revises Earnings Guidance for the Fiscal Year Ending June 30, 2023